Actualités Actualités Actualités

Actualités

Portfolio

Fronnt further expands and strengthens its offering through the acquisition of Bovema International

06/02/2024 - 13:08

Portefeuille

Gimv acts as co-lead investor in a €30M Series C financing round at Onera Health

16/01/2024 - 07:30

Portfolio

AME and Variass join forces by establishing Metis Group

09/01/2024 - 16:20

Portefeuille

Gimv investit dans Castelein Sealants pour accélérer la croissance europeénne

19/12/2023 - 07:30

Portefeuille

WEMAS partners with Sekisui Jushi Corporation (“SJC”) to pursue further expansion after growth journey alongside Gimv and Paragon Partners

08/12/2023 - 12:00

Corporate

Gimv welcomes WorxInvest as reference shareholder

30/11/2023 - 21:24

Corporate

Strong results confirm strategy of value creation through growth

23/11/2023 - 06:58

Portfolio

Mediar Therapeutics Announces Clinical Candidates for Lead Fibrosis Programs, Strategic Collaborations and Key Leadership Addition

25/10/2023 - 16:52

Portfolio

Projective Group announces latest acquisition and biggest brand move yet

23/10/2023 - 14:07

Portfolio

ImCheck to Present New Positive Data on ICT01 Monotherapy in Hematological Cancers at ESMO 2023

18/10/2023 - 08:19

Portfolio

Spineart has reached and surpassed €100M of revenue.

17/10/2023 - 15:43

Portfolio

ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA

17/10/2023 - 10:56

Contact médias

Investor Relations Investor Relations Investor Relations

Investor Relations

Avez-vous des questions ou vous désiriez obtenir plus d'informations?
N'hésitez pas à nous contacter.